PUGLISI, FRANCESCO THOMAS
 Distribuzione geografica
Continente #
EU - Europa 607
NA - Nord America 113
AS - Asia 100
SA - Sud America 7
AF - Africa 3
Totale 830
Nazione #
IT - Italia 591
US - Stati Uniti d'America 104
SG - Singapore 36
VN - Vietnam 23
CN - Cina 18
BD - Bangladesh 12
BR - Brasile 6
CA - Canada 5
DE - Germania 5
HK - Hong Kong 5
FR - Francia 4
IQ - Iraq 2
NL - Olanda 2
AL - Albania 1
BB - Barbados 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
FI - Finlandia 1
GB - Regno Unito 1
ID - Indonesia 1
JM - Giamaica 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 830
Città #
Genoa 263
Genova 187
Rapallo 61
Vado Ligure 60
San Jose 21
Ashburn 18
Ho Chi Minh City 13
Singapore 13
Beijing 7
Council Bluffs 6
Hanoi 5
Hong Kong 5
Los Angeles 5
Frankfurt am Main 4
Lauterbourg 4
Rome 4
Bologna 3
Chicago 3
Santa Clara 3
Amsterdam 2
Buffalo 2
Ferno 2
Milan 2
Milwaukee 2
Waco 2
Winnipeg 2
Baghdad 1
Baltimore 1
Bandar Lampung 1
Bangkok 1
Basingstoke 1
Biên Hòa 1
Bridgetown 1
Bắc Giang 1
Cairo 1
Calgary 1
Camden 1
Caxias do Sul 1
Cedar Falls 1
Cranbrook 1
Dallas 1
Divinópolis 1
Elmont 1
Fayetteville 1
Gainesville 1
Goiás 1
Grove City 1
Hai Bà Trưng 1
Helsinki 1
Houston 1
Hải Dương 1
Johor Bahru 1
Leipzig 1
Lynchburg 1
Mahomet 1
Manaus 1
Mexico City 1
Miami 1
Miaoli 1
Middelburg 1
Montreal 1
Mérida 1
Naples 1
New York 1
North Bergen 1
Oak Ridge 1
Orlando 1
Oslo 1
Ozzano dell'Emilia 1
Paw Paw 1
Phoenix 1
Prague 1
Qingdao 1
Queens 1
Ramadi 1
Rolândia 1
San Salvador 1
Saïda 1
Seattle 1
St. Petersburg 1
Syosset 1
São Paulo 1
Tianjin 1
Tirana 1
Turin 1
Wadesboro 1
West Hartford 1
Woodstock 1
Totale 761
Nome #
"Green-reduced" graphene oxide induces in vitro an enhanced biomimetic mineralization of polycaprolactone electrospun meshes 235
Studio dei fattori responsabili dell’alterazione del metabolismo osseo nella Leucemia Linfatica Cronica: specifico ruolo di HGF nel microambiente stromale. 186
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 143
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: Extending endocrine sensitivity 131
Comparing Outcomes Between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease 93
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives 65
Totale 853
Categoria #
all - tutte 2.949
article - articoli 2.458
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202275 1 3 7 6 6 7 2 11 4 5 6 17
2022/202379 7 5 0 5 8 12 2 8 15 1 13 3
2023/202456 1 3 2 13 5 7 3 7 0 3 4 8
2024/2025146 6 12 7 13 14 10 11 23 2 4 21 23
2025/2026342 40 14 33 32 47 21 33 19 25 35 24 19
2026/202726 26 0 0 0 0 0 0 0 0 0 0 0
Totale 853